Trials / Completed
CompletedNCT00413231
Valor II: The Valiant Thoracic Stent Graft System Clinical Study
The Valiant Thoracic Stent Graft System. The Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to study safety and effectiveness of the Valiant Thoracic Stent Graft to treat thoracic aortic aneurysms.
Detailed description
The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. In this research study we are investigating a device that can be placed in the aorta to exclude the weakened part of the artery wall and restore blood flow. Information will be collected on the performance of the device for 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Valiant Thoracic Stent Graft System | Surgical procedure in which a device is implanted inside the aorta, isolating the diseased area (aneurysm). |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2010-08-01
- Completion
- 2014-10-01
- First posted
- 2006-12-19
- Last updated
- 2021-11-03
- Results posted
- 2012-04-05
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00413231. Inclusion in this directory is not an endorsement.